The-Shift-Shapers-Podcast-(Rough-Comp-2)

With 23% of the US population using 3 or more prescription drugs, it is amazing that many physicians are still (essentially) guessing which drugs to prescribe. Adverse drug events cause 1 million ED visits, 280,000 hospitalizations and are the fourth leading cause of preventable death. But pharmacogenomics can alleviate all of those AND lower costs while providing a much better patient experience. Joe Spinelli, this week’s guest, explains how and talks about why your employer clients should be using this tool.

What You’ll Learn From this Episode:

  • What is pharmacogenomics.
  • What it costs.
  • What it delivers.
  • How to talk to your prospects/clients about using this tool.

Featured on the Show:

Listen to the Full Interview:

This Episode is Sponsored by:

Enjoy The Show?

Subscribe-with-iTunes-smallSubscribe-with-Stitcher-smalliHeartRadio-small

The-Shift-Shapers-Podcast-(Rough-Comp-2)

Musculoskeletal  claims  represent  16-22%  of  medical  spend  in  most  plans.  Yet  with  a  misdiagnosis  rate  of  nearly  40%  and  with  new  evaluative  and  treatment  regimens,  plans  can  save  as  much  as  25-35%  of  that  spend.

Chad  Gray,  CEO  at  Integrated  Musculoskeletal  Care)  has  been  tracking  this  trend  and  is  one  of  the  foremost  experts  on  how  plans  can  provide  better  quality  care  while  lowering  costs  in  this  space.

What You’ll Learn From this Episode:

  • How big is this spend?
  • What Chad’s background is and how it informs decision making.
  • Where the breakdown begins.
  • How analysis deals with the variability of these claims.
  • What the “grand rounds” methodology is.

Featured on the Show:

Listen to the Full Interview:

This Episode is Sponsored by:

Enjoy The Show?

Subscribe-with-iTunes-smallSubscribe-with-Stitcher-smalliHeartRadio-small